Phosphatidylserine reverses reserpine-induced amnesia

European Journal of Pharmacology

Volumn 404, Issue 1-2, 2000, Pages 161-167

  Alves, Célia S D ^a   Andreatini, Roberto ^a   Da Cunha, Cláudio ^a   Tufik, Sérgio ^b   Vital, Maria A B F ^a  

^a Dept Pharmacol Fed Univ P   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Memory; Passive avoidance; Phosphatidylserine; Reserpine

Indexed keywords

PHOSPHATIDYLSERINE; RESERPINE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATECHOLAMINE DEPLETION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG ACTIVITY; MALE; NONHUMAN; PARKINSON DISEASE; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT;

AMNESIA; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; MALE; PHOSPHATIDYLSERINES; RATS; RATS, WISTAR; RESERPINE;

EID: 0034666623     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00607-5     Document Type: Article

References (38)

1. Allen C., Allen B.S., Rake A.V. Pharmacological distinctions between "active" and "passive" avoidance memory formation as shown by manipulation of biogenic amine active compounds. Psychopharmacologia. 34:1974;1-10.
2. Angelucci M.E.M., Vital M.A.B.F., Cesario C., Zadusky C.R., Rosalen P.L., Cunha D., Cunha C. The effect of caffeine in animal models of learning and memory. Eur. J. Pharmacol. 373:1999;135-140.
3. Archer T., Danysz W., Fredriksson A., Jonsson G., Luthman J., Sundström E., Teiling A. Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning. Pharmacol. Biochem. Behav. 31:1988;357-364.
4. Bevilaqua L., Ardenghi P., Schröder N., Bromberg E., Schmitz P.K., Schaeffer E., Quevedo J., Bianchin M., Walz R., Medina J.H., Izquierdo I. Drugs acting upon cyclic adnosine monophosphate/protein kinase A signalling pathway modulate memory consolidation when given late after training into rat hippocampus but not amygdala. Behav. Pharmacol. 8:1997;331-338.
5. Breckenridge W.C., Gombos G., Morgan I.G. The lipid composition of adult rat brain syynaptosomal plasma membranes. Biochem. Biophys. Acta. 266:1972;695-707.
6. Bruni A., Toffano G., Leom A., Boarato E. Pharmacological effects of phosphatidylserine liposomes. Nature. 260:1976;331-333.
7. Carlsson A. Monoamine-depleting drugs. Pharmac. Ther. 1:1975;393-400.
8. Castellano C., Introinicollison I.B., McGaugh J.L. Interaction of beta-endorphin and gabaergic drugs in the regulation of memory storage. Behav. Neur. Biol. 60:1993;123-128.
9. Claro F.T., Silva R.H., Frussa-Filho R. Bovine brain phosphatidylserine attenuates scopolamine-induced amnesia. Physiol. Behav. 67:1999;551-554.
10. Cohen S.A., Müller W.E. Age-related alterations of NMDA-receptor properties in the mouse forebrain: partial restoration by chronic phosphatidylserine treatment. Brain Res. 584:1992;174-180.
11. Colpaert F.C. Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat. Neuropharmacol. 26:1987;1431-1440.
12. Dismukes R.K., Rake A.V. Involvement of biogenic amines in memory formation. Psychopharmacologia. 23:1972;17-25.
13. Drago F., Canonico P.L., Scapagnini U. Behavioral effects of phosphatidylserine in aged rats. Neurobiol. Aging. 2:1981;209-213.
14. Drago F., Toffano G., Danielli L.C.R., Continella G., Scapagnini U. Phosphatidylserine facilitates learning and memory process in aged rats. Samuel D. Aging of the Brain. 1983;308-316.
15. Fagioli S., Castellano C., Oliverio A., Pavone F., Populin R., Toffano G. Phosphatidylserine administration during postnatal development improves memory in adult mice. Neurosci. Lett. 101:1989;229-233.
16. Gelbmann C.M., Müller E. Chronic treatment with phosphatidylserine restores muscarinic cholinergic receptor deficits in the aged mouse brain. Neurobiol. Aging. 13:1991;45-90.
17. Gerlach M., Riederer P. Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J. Neural Transm. 103:1996;987-1041.
18. Goldman-Rakic P.S. The cortical dopamine system: role in memory and cognition. Adv. Pharmacol. 42:1998;707-711.
19. Heffner T.G., Seiden L.S. Impaired acquisition of an operant response in young rats depleted of brain dopamine in neonatal life. Psychopharmacology. 79:1983;115-119.
20. Izquierdo I., Medina J.H. Memory formation: the sequence of biochemical events in the hippocampus and its connection to acitivity in other brain structures. Neurobiol. Learn. Mem. 68:1997;285-316.
21. Kurtz P., Palfai T. Effects of reserpine on retention of escape reversal in mice: absence of state-dependent learning. J Comp. Physiol. Psychol. 11:1977;393-406.
22. Maggioni M., Picotti G.B., Bondiolotti G.P., Panerai A., Cenacchi T., Nobile P., Brambilla F. Effects of phosphatidylserine therapy in geriatric patients with depressive disorders. Acta Psychiatr. Scand. 81:1990;265-270.
23. Mantovani P., Pepeu G., Amaducci L. Investigation into the relationship between phospholipids and brain acetylcholine. Adv. Exp. Med. Biol. 72:1976;285-292.
24. Mazzari S., Battistela A. Phosphatidylserine effect on dopamine release from striatum synaptosomes. Di Benedetto C. A Multidisciplinary Approach to Brain Development. 1980;145-154 Elsevier/North-Holland Medical Press, Amsterdam.
25. Mazzari S., Zanotti A., Orlando P., Raciti R., Toffanno G. Pharmacokinetics and pharmacodynamics of phosphatidylserine liposomes in mice. Antolini A. Transport in Biomembranes: "Model System and Reconstruction" 1982;257-263 Raven Press, New York.
26. McGaugh J.L. Involvement of hormonal and neuromodulatory systems in the regulation of memory storage. Annu. Ver. Neurosci. 12:1989;255-287.
27. Packard M.G., White N.M. Dissociation of hippocampus and caudate nucleus memory systems by posttraining intracerebral injection of dopamine agonists. Behav. Neurosci. 105:1991;295-306.
28. Raiteri M., Marchi M., Maura G., Ferlito M., Fontana G., Robino G. Selective recovery of neurotransmitter release in aged rat brain after chronic phosphatidylserine. Freysz L., Hawthorne J.N., Toffano G. Neurochemical Aspects of Phospholipid Metabolism. 1989;219-224 Liviana Press, Padova, Italy.
29. Rake A.V. Involvement of biogenic amines in memory formation: the central nervous system indole amine involvement. Psychopharmacologia. 29:1973;91-100.
30. Sahgal A. Passive avoidance procedures. Sahgal A. Behavioural Neuroscience: A Practical Approach. vol. I:1993;49-56 Oxford Univ. Press, Oxford.
31. Smith A., Loh H.H. The topographical distribution of phosphatidylethanolamine and phosphatidylserine in synaptosomal plasma membrane. Proc. West. Pharmacol. Soc. 19:1976;147-151.
32. Toffano G., Leon A., Benvegnu D., Boarato E., Azzone G.F. Effects of brain cortex phospholipids on catecholamine content of mouse brain. Pharmac. Res. Commun. 8:1976;581-590.
33. Toffano G., Leon A., Mazzari S., Savoini G., Teolato S., Orlando P. Modification of noradrenergic hypothalamic system in rats injected with phosphatidylserine liposomes. Life Sci. 23:1978;1093-1102.
34. Valldeoriola F., Nobbe F.A., Tolosa E. Treatment of behavioural disturbances in Parkinson's disease. J. Neural Transm. 51:1997;175-204.
35. Walsh T.J., Palfai T. Time-dependent effects of reserpine on retention of passive avoidance. Pharmacol. Biochem. Behav. 8(2):1978;103-105.
36. Weiskrantz L., Wilson W.A. Effects of reserpine on learning and performance. Science. 123:1956;1110-1118.
37. Zanotti A., Aporti F., Rubini R., Toffano G. Reversal of scopolamine-induced amnesia by phosphatidylserine in rats. Psychopharmacology. 90:1986;274-275.
38. Zanotti A., Valzelli L., Toffano G. Chronic phosphatidylserine treatment improves spatial memory and passive avoidance in aged rats. Psychopharmacology. 99:1989;316-321.